June 2016

Atomo is delighted to announce that the company has secured  $1.38 million in grant funding from the Australian Government to assist in the development and commercialisation of new rapid tests for the detection of dengue and chikungunya viruses. Half the world’s population live in areas at risk...

Atomo’s CEO describes the company’s innovations in rapid diagnostics on Sky News Atomo Group CEO, John Kelly, was invited to talk with Peter Switzer on Sky News on 25 July 2016 to discuss the company’s continuing success in the diagnostic technology sector. Atomo has attracted high-profile support...